Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Adrian V. Hernandez, Jennifer Hwang, Iram Nasreen, Dakota Sicignano, Vinay Pasupuleti, Kimberly Snow-Caroti & C. Michael White. (2023) Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis. Journal of Dietary Supplements 0:0, pages 1-18.
Read now
Read now
Song Liu, Xiaojun Cai, Tao Wang, Jiwen Xu, Weilun Cheng, Xuling Wang, Gangjie Wei & Shuang Yan. (2022) Downregulation of ALDH6A1 is a New Marker of Muscle Insulin Resistance in Type 2 Diabetes Mellitus. International Journal of General Medicine 15, pages 2137-2147.
Read now
Read now
Giuseppe Derosa, Angela D’Angelo, Arianna Vanelli & Pamela Maffioli. (2020) An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia. Diabetes, Metabolic Syndrome and Obesity 13, pages 653-661.
Read now
Read now
Sergio D’Addato, Luciana Scandiani, Giuliana Mombelli, Francesca Focanti, Federica Pelacchi, Enrica Salvatori, Giorgio Di Loreto, Alessandro Comandini, Pamela Maffioli & Giuseppe Derosa. (2017) Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: a randomized, double-blind, placebo controlled study. Drug Design, Development and Therapy 11, pages 1585-1592.
Read now
Read now
Sandy Elbitar, Petra El Khoury, Youmna Ghaleb, Jean-Pierre Rabès, Mathilde Varret, Nabil G. Seidah, Catherine Boileau & Marianne Abifadel. (2016) Proprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015). Expert Opinion on Therapeutic Patents 26:12, pages 1377-1392.
Read now
Read now
Giuseppe Derosa & Pamela Maffioli. (2015) Nutraceuticals for the treatment of metabolic diseases: evidence from clinical practice. Expert Review of Endocrinology & Metabolism 10:3, pages 297-304.
Read now
Read now
Giuseppe Derosa, Aldo Bonaventura, Lucio Bianchi, Davide Romano, Angela D'Angelo, Elena Fogari & Pamela Maffioli. (2013)
Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients. Expert Opinion on Biological Therapy 13:11, pages 1495-1506.
Read now
Read now
Paramjit S Tappia, Yan–Jun Xu & Naranjan S Dhalla. (2013) Reduction of cholesterol and other cardiovascular disease risk factors by alternative therapies. Clinical Lipidology 8:3, pages 345-359.
Read now
Read now
Articles from other publishers (67)
Jie V. Zhao, Xin Huang, Junmeng Zhang, Yap-Hang Chan, Hung-Fat Tse & Joseph E. Blais. (2023) Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Journal of Nutrition 153:10, pages 2939-2950.
Crossref
Crossref
Alfredo Caturano, Margherita D’Angelo, Andrea Mormone, Vincenzo Russo, Maria Pina Mollica, Teresa Salvatore, Raffaele Galiero, Luca Rinaldi, Erica Vetrano, Raffaele Marfella, Marcellino Monda, Antonio Giordano & Ferdinando Carlo Sasso. (2023) Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications. Current Issues in Molecular Biology 45:8, pages 6651-6666.
Crossref
Crossref
Hao-Jian Zhang, Yan Wang & Jian-Dong Jiang. (2023) Drug-gut Microbiome Interaction in Atherosclerosis Therapeutics. Current Drug Metabolism 24:7, pages 482-492.
Crossref
Crossref
Lianliang Liu, Yueqin Li, Lezhen Dong, Yunzhen Zhang, Zufang Wu & Jianbo Xiao. 2023. Dietary Supplements with Antioxidant Activity. Dietary Supplements with Antioxidant Activity
40
79
.
Lubi Lei, Jingkuo Li & Bin Wang. (2023) Efficacy and Safety Profile of Berberine Treatment in Improving Risk Factors for Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized, Double-blind Trials. Cardiology Discovery 3:2, pages 112-121.
Crossref
Crossref
Xiaoyu Xuan, Jingyi Zhang, Jilin Fan & Shiliang Zhang. (2023) Research progress of Traditional Chinese Medicine (TCM) in targeting inflammation and lipid metabolism disorder for arteriosclerosis intervention: A review. Medicine 102:18, pages e33748.
Crossref
Crossref
Joseph E. Blais, Xin Huang & Jie V. Zhao. (2023) Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Drugs 83:5, pages 403-427.
Crossref
Crossref
Caroline Bertoncini‐Silva, Jean‐Marc Zingg, Priscila Giacomo Fassini & Vivian Marques Miguel Suen. (2022) Bioactive dietary components—Anti‐obesity effects related to energy metabolism and inflammation. BioFactors 49:2, pages 297-321.
Crossref
Crossref
Mohammad Zamani, Mahtab Zarei, Mahlagha Nikbaf-Shandiz, Shabnam Hosseini, Farideh Shiraseb & Omid Asbaghi. (2022) The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis. Frontiers in Nutrition 9.
Crossref
Crossref
Ashwani Kumar, Komal, Rakesh Kumar, Ghan Shyam Abrol, Pooja Kumari & P. Nirmal. (2022) A review on the nutritional composition, phytochemicals, and health benefits of barberry: An insight into culinary applications and future prospects. Journal of Food Processing and Preservation 46:10.
Crossref
Crossref
Anlu Wang, Baoyi Guan, Chang Shao, Lin Zhao, Qiuyi Li, Haiping Hao, Zhuye Gao, Keji Chen, Yuanlong Hou & Hao Xu. (2022) Qing-Xin-Jie-Yu Granule alleviates atherosclerosis by reshaping gut microbiota and metabolic homeostasis of ApoE-/- mice. Phytomedicine 103, pages 154220.
Crossref
Crossref
Shu-Rong Ma, Qian Tong, Yuan Lin, Li-Bin Pan, Jie Fu, Ran Peng, Xian-Feng Zhang, Zhen-Xiong Zhao, Yang Li, Jin-Bo Yu, Lin Cong, Pei Han, Zheng-Wei Zhang, Hang Yu, Yan Wang & Jian-Dong Jiang. (2022) Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Tapan Behl, Sukhbir Singh, Neelam Sharma, Ishrat Zahoor, Ali Albarrati, Mohammed Albratty, Abdulkarim M. Meraya, Asim Najmi & Simona Bungau. (2022) Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends. Molecules 27:12, pages 3705.
Crossref
Crossref
Dongdong Wang, Jiansheng Huang, Ting Gui, Yaxin Yang, Tingting Feng, Nikolay T. Tzvetkov, Tao Xu, Zhibo Gai, Ying Zhou, Jingjie Zhang & Atanas G. Atanasov. (2022) SR-BI as a target of natural products and its significance in cancer. Seminars in Cancer Biology 80, pages 18-38.
Crossref
Crossref
Smriti Suri, Prasenjit Mitra, Abhilasha Abhilasha, Indu Saxena, Mahendra K. Garg, Gopal Krishna Bohra & Praveen Sharma. (2022) Role of interleukin-2 and interleukin-18 in newly diagnosed type 2 diabetes mellitus. Journal of Basic and Clinical Physiology and Pharmacology 33:2, pages 185-190.
Crossref
Crossref
Xianzhi Liu, Lifu Wang, Siwei Tan, Zebin Chen, Bin Wu & Xiaoying Wu. (2022) Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora. Frontiers in Pharmacology 13.
Crossref
Crossref
MeiYan Chan, Zongshi Qin, Sui‐Cheung Man, Ming Lam, Wing Him Lai, Roger Man Kin Ng, Che Kin Lee, Tak Luen Wong, Edwin Ho Ming Lee, Hei Kiu Wong, Yibin Feng, Lanying Liu, Feng Han, Eric Yu Hai Chen & Zhang‐Jin Zhang. (2022)
Adjunctive berberine reduces
antipsychotic‐associated
weight gain and metabolic syndrome in patients with schizophrenia: a randomized controlled trial
. Psychiatry and Clinical Neurosciences 76:3, pages 77-85.
Crossref
Crossref
Richard Y. Cao, Ying Zhang, Zhen Feng, Siyu Liu, Yifan Liu, Hongchao Zheng & Jian Yang. (2021) The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis. Frontiers in Pharmacology 12.
Crossref
Crossref
Ying Zhao, Yuan-Yuan Yang, Bao-Lin Yang, Ya-Wei Du, Da-Wei Ren, Hong-Mei Zhou, Jing Wang, Hui-Min Yang, Yao-Xian Wang, Ying-Ying Zhang & Sheng-Xian Wu. (2021) Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial. Trials 22:1.
Crossref
Crossref
Narges Hedayati, Zahra Oskouei, Jamshid Tabeshpour & Mehri Bemani Naeini. (2021) Berberine and lycopene as alternative or add-on therapy to metformin and statins, a review. European Journal of Pharmacology 913, pages 174590.
Crossref
Crossref
Lu Xing, Xin Zhou, Ai-Hong Li, Hui-Jin Li, Chun-Xia He, Wei Qin, Dong Zhao, Peng-Quan Li, Li Zhu & Hui-Ling Cao. (2021) Atheroprotective Effects and Molecular Mechanism of Berberine. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Xiao-Fang Yang, Ming Lu, Lijiao You, Huan Gen, Lin Yuan, Tianning Tian, Chun-Yu Li, Kailiang Xu, Jie Hou & Ming Lei. (2021) Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology. Chinese Medicine 16:1.
Crossref
Crossref
Jie V. Zhao, Wai-Fung Yeung, Yap-Hang Chan, Dana Vackova, June Y. Y. Leung, Dennis K. M. Ip, Jiaxi Zhao, Wai-Kwan Ho, Hung-Fat Tse & Catherine Mary Schooling. (2021) Effect of Berberine on Cardiovascular Disease Risk Factors: A Mechanistic Randomized Controlled Trial. Nutrients 13:8, pages 2550.
Crossref
Crossref
Giuseppe Derosa, Pamela Maffioli, Angela D’Angelo & Francesco Di Pierro. (2021) Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications. Frontiers in Immunology 12.
Crossref
Crossref
Shengju Wang, Zhang Xu, Baochao Cai & Qiu Chen. (2021) Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:6, pages 971-979.
Crossref
Crossref
Haixia Du, Chang Li, Zhixiong Wang, Yu He, Yu Wang, Huifen Zhou, Haitong Wan & Jiehong Yang. (2021) Effects of Danhong injection on dyslipidemia and cholesterol metabolism in high-fat diets fed rats. Journal of Ethnopharmacology 274, pages 114058.
Crossref
Crossref
Yu Ye, Xiufen Liu, Ninghua Wu, Yanqi Han, Jiawen Wang, Yuandong Yu & Qingjie Chen. (2021) Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Frontiers in Pharmacology 12.
Crossref
Crossref
Xingxing Li, Chunyan Su, Zhibo Jiang, Yuxin Yang, Yue Zhang, Mengxia Yang, Xiumin Zhang, Yu Du, Jin Zhang, Li Wang, Jiandong Jiang & Bin Hong. (2021) Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. npj Biofilms and Microbiomes 7:1.
Crossref
Crossref
Yan Wang, Qian Tong, Shu-Rong Ma, Zhen-Xiong Zhao, Li-Bin Pan, Lin Cong, Pei Han, Ran Peng, Hang Yu, Yuan Lin, Tian-Le Gao, Jia-Wen Shou, Xiao-Yang Li, Xian-Feng Zhang, Zheng-Wei Zhang, Jie Fu, Bao-Ying Wen, Jin-Bo Yu, Xuetao Cao & Jian-Dong Jiang. (2021) Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Lichao Zhang, Xiaoying Wu, Ruibing Yang, Fang Chen, Yao Liao, Zifeng Zhu, Zhongdao Wu, Xi Sun & Lifu Wang. (2021) Effects of Berberine on the Gastrointestinal Microbiota. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Juan M. León-MartínezEsperanza Martínez-AbundisManuel González-OrtizKarina G. Pérez-Rubio. (2021) Effect of Berberine Plus Bezafibrate Administration on the Lipid Profile of Patients with Mixed Dyslipidemia: A Pilot Clinical Trial. Journal of Medicinal Food 24:2, pages 111-115.
Crossref
Crossref
Xinmei Xu, Huan Yi, Jiasi Wu, Tingting Kuang, Jing Zhang, Qi Li, Huan Du, Tong Xu, Guihua Jiang & Gang Fan. (2021) Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomedicine & Pharmacotherapy 133, pages 110984.
Crossref
Crossref
Giuseppe DerosaAlessandro CollettiPamela MaffioliAngela D’AngeloAlessandro LupiGiovanni B. ZitoGian Francesco MuredduRiccardo RaddinoFrancesco FedeleArrigo F.G. Cicero. (2020) Lipid-lowering nutraceuticals update on scientific evidence. Journal of Cardiovascular Medicine 21:11, pages 845-859.
Crossref
Crossref
Atena Mahdavi, Mohammad Bagherniya, Omid Fakheran, Željko Reiner, Suowen Xu & Amirhossein Sahebkar. (2020)
Medicinal plants and bioactive natural compounds as inhibitors of
HMG‐CoA
reductase: A literature review
. BioFactors 46:6, pages 906-926.
Crossref
Crossref
Danyang Song, Jianyu Hao & Daiming Fan. (2020) Biological properties and clinical applications of berberine. Frontiers of Medicine 14:5, pages 564-582.
Crossref
Crossref
Omid Asbaghi, Niloofar Ghanbari, Mahdi shekari, Željko Reiner, Elaheh Amirani, Jamal Hallajzadeh, Liaosadat Mirsafaei & Zatollah Asemi. (2020) The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN 38, pages 43-49.
Crossref
Crossref
T Santhi & K Balu Mahendran. (2020) High-sensitivity C-reactive protein, Malondialdehyde and their association with Glycated hemoglobin (HbA1c)in type 2 diabetes patients. International Journal of Clinical Biochemistry and Research 7:1, pages 57-61.
Crossref
Crossref
Hui Wang, Yao Huang, Pan Shen, Yu Wang, Kai Qin, Ying Huang, Xin Ba, Weiji Lin, Zhe Chen & Shenghao Tu. (2020) Modified Si-Miao Pill for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-12.
Crossref
Crossref
Pan Xiong, Li Niu, Sam Talaei, Hamed Kord-Varkaneh, Cain C.T. Clark, Mihnea-Alexandru Găman, Jamal Rahmani, Masoumeh Dorosti, Seyed Mohammad Mousavi, Meysam Zarezadeh, Hossein Taghizade-Bilondi & Jitao Zhang. (2020) The effect of berberine supplementation on obesity indices: A dose– response meta-analysis and systematic review of randomized controlled trials. Complementary Therapies in Clinical Practice 39, pages 101113.
Crossref
Crossref
Mohammad Reza Amini, Fatemeh Sheikhhossein, Sina Naghshi, Farhang Djafari, Mohammadreza Askari, Hossein Shahinfar, Maryam Safabakhsh, Alireza Jafari & Sakineh Shab-Bidar. (2020) Effects of berberine and barberry on anthropometric measures: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine 49, pages 102337.
Crossref
Crossref
Alireza Fatahian, Saeed Mohammadian Haftcheshmeh, Sara Azhdari, Helaleh Kaboli Farshchi, Banafsheh Nikfar & Amir Abbas Momtazi-Borojeni. 2020. Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology
83
110
.
Liangzhen Xie, Duojia Zhang, Hongli Ma, Hui He, Qing Xia, Wenjuan Shen, Hui Chang, Yingying Deng, Qi Wu, Jing Cong, Chi Chiu Wang & Xiaoke Wu. (2019) The Effect of Berberine on Reproduction and Metabolism in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Control Trials. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-14.
Crossref
Crossref
Nan Zhang, Mingwei Sheng, Man Wu, Xinyue Zhang, Yijie Ding, Yuanbang Lin, Wenli Yu, Shusen Wang & Hongyin Du. (2019) Berberine protects steatotic donor undergoing liver transplantation via inhibiting endoplasmic reticulum stress-mediated reticulophagy. Experimental Biology and Medicine 244:18, pages 1695-1704.
Crossref
Crossref
Xinyu Ji, Shuai Shi, Bin Liu, Mingxu Shan, Danli Tang, Wantong Zhang, Yin Zhang, Lulu Zhang, Huamin Zhang, Cheng Lu & Yongyan Wang. (2019) Bioactive compounds from herbal medicines to manage dyslipidemia. Biomedicine & Pharmacotherapy 118, pages 109338.
Crossref
Crossref
Michele Scognamiglio, Dario Costa, Antonio Sorriento & Claudio Napoli. (2019) Current Drugs and Nutraceuticals for the Treatment of Patients with Dyslipidemias. Current Pharmaceutical Design 25:1, pages 85-95.
Crossref
Crossref
Shu-Rong Ma, Qian Tong, Zhen-Xiong Zhao, Lin Cong, Jin-Bo Yu, Jie Fu, Pei Han, Li-Bin Pan, Randy Gu, Ran Peng, Zheng-Wei Zhang, Yan Wang & Jian-Dong Jiang. (2019) Determination of berberine-upregulated endogenous short-chain fatty acids through derivatization by 2-bromoacetophenone. Analytical and Bioanalytical Chemistry 411:14, pages 3191-3207.
Crossref
Crossref
Amir Hadi, Arman Arab, Ehsan Ghaedi, Nahid Rafie, Maryam Miraghajani & Marzieh Kafeshani. (2019) Barberry (Berberis vulgaris L.) is a safe approach for management of lipid parameters: A systematic review and meta‐analysis of randomized controlled trials. Complementary Therapies in Medicine 43, pages 117-124.
Crossref
Crossref
Lei Qiao & Wenqiang Chen. (2018) Atheroprotective effects and molecular targets of bioactive compounds from traditional Chinese medicine. Pharmacological Research 135, pages 212-229.
Crossref
Crossref
Yanwen Wang & Jeffrey A. Zidichouski. (2018) Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis. Cholesterol 2018, pages 1-17.
Crossref
Crossref
Joe W.E. Moss, Jessica O. Williams & Dipak P. Ramji. (2018) Nutraceuticals as therapeutic agents for atherosclerosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:5, pages 1562-1572.
Crossref
Crossref
Ru Feng, Zhen-Xiong Zhao, Shu-Rong Ma, Fang Guo, Yan Wang & Jian-Dong Jiang. (2018) Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration. Frontiers in Pharmacology 9.
Crossref
Crossref
Laura M. Koppen, Andrea Whitaker, Audrey Rosene & Robert D. Beckett. (2017) Efficacy of Berberine Alone and in Combination for the Treatment of Hyperlipidemia: A Systematic Review. Journal of Evidence-Based Complementary & Alternative Medicine 22:4, pages 956-968.
Crossref
Crossref
Yan Wang, Jia-Wen Shou, Xiao-Yang Li, Zhen-Xiong Zhao, Jie Fu, Chi-Yu He, Ru Feng, Chao Ma, Bao-Ying Wen, Fang Guo, Xin-Yi Yang, Yan-Xing Han, Lu-Lu Wang, Qian Tong, Xue-Fu You, Yuan Lin, Wei-Jia Kong, Shu-Yi Si & Jian-Dong Jiang. (2017) Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. Metabolism 70, pages 72-84.
Crossref
Crossref
Mohsen Imenshahidi & Hossein Hosseinzadeh. (2016)
Berberis Vulgaris
and Berberine: An Update Review
. Phytotherapy Research 30:11, pages 1745-1764.
Crossref
Crossref
Xiaopeng Zhu, Hua Bian & Xin Gao. (2016) The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease. Molecules 21:10, pages 1336.
Crossref
Crossref
Giuseppe Derosa, Angela D'Angelo & Pamela Maffioli. (2016) The role of a fixed Berberis aristata/Silybum marianum combination in the treatment of type 1 diabetes mellitus. Clinical Nutrition 35:5, pages 1091-1095.
Crossref
Crossref
Joe W. E. Moss & Dipak P. Ramji. (2016) Nutraceutical therapies for atherosclerosis. Nature Reviews Cardiology 13:9, pages 513-532.
Crossref
Crossref
Qichun Zhang, Huimin Bian, Liwei Guo & Huaxu Zhu. (2016) Berberine Preconditioning Protects Neurons Against Ischemia via Sphingosine-1-Phosphate and Hypoxia-Inducible Factor-1α. The American Journal of Chinese Medicine 44:05, pages 927-941.
Crossref
Crossref
Angela Pirillo & Alberico Luigi Catapano. (2015) Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies. Atherosclerosis 243:2, pages 449-461.
Crossref
Crossref
Wenguang ChangLi ChenGrant M. Hatch. (2015) Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. Biochemistry and Cell Biology 93:5, pages 479-486.
Crossref
Crossref
Giuseppe Derosa & Pamela Maffioli. (2015) Possible therapies for obesity: Focus on the available options for its treatment. Nutrition 31:3, pages 542-543.
Crossref
Crossref
Giuseppe Derosa, Davide Romano, Angela D'Angelo & Pamela Maffioli. (2015) Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. Atherosclerosis 239:1, pages 87-92.
Crossref
Crossref
Giuseppe Derosa, Davide Romano, Angela D'Angelo & Pamela Maffioli. (2015) Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. Phytomedicine 22:2, pages 231-237.
Crossref
Crossref
Jaime P. Almandoz. 2015. Dyslipidemias. Dyslipidemias
383
402
.
Zemin Yao, Li Zhang & Guang Ji. (2014) Efficacy of polyphenolic ingredients of Chinese herbs in treating dyslipidemia of metabolic syndromes. Journal of Integrative Medicine 12:3, pages 135-146.
Crossref
Crossref
Amar Bahadur SinghHai LiChin Fung Kelvin KanBin DongMark R. NicollsJingwen Liu. (2014) The Critical Role of mRNA Destabilizing Protein Heterogeneous Nuclear Ribonucleoprotein D in 3′ Untranslated Region–Mediated Decay of Low-Density Lipoprotein Receptor mRNA in Liver Tissue. Arteriosclerosis, Thrombosis, and Vascular Biology 34:1, pages 8-16.
Crossref
Crossref
Yang Liu, Li Zhang, Haiyan Song & Guang Ji. (2013) Update on Berberine in Nonalcoholic Fatty Liver Disease. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-8.
Crossref
Crossref